Ciwon sankarar lymphoblastic mai tsanani (T-ALL)-08

Yesheng daga Fujian ya ce, "Da na san game da CAR-T a BIOOCUS Medical Group, da na zo da wuri."

A watan Satumba na 2017, Yesheng ya kamu da kuraje a fuska, wanda a hankali ya bazu ya zama faci. Zuwa ranar 28 ga Fabrairu, 2018, gwajin ƙashi ya tabbatar da "cutar cutar sankarar lymphoblastic mai tsanani ta T-cell" bayan an yi amfani da maganin chemotherapy sau da yawa, tare da gwaje-gwajen da ba su da kyau a lokaci-lokaci. An dakatar da duk magunguna a watan Yuni na 2019.

A watan Mayu na 2021, Yesheng ya sami tarin abubuwa a yankin baki da makogwaro da kuma ƙananan ƙwayoyin lymph na wuya. Sake duba ƙashi ya tabbatar da sake dawowar cutar sankarar bargo gaba ɗaya. A ranar 28 ga Mayu, an mayar da Yesheng zuwa Sashen Kula da Cututtukan Jini na Biyu don a yi masa magani. Bayan cikakken bincike, an sake duba cutar zuwa "cutar sankarar bargo mai tsanani (T/myeloid biphenotypic)."

Sau ɗaya na zagayowar maganin chemotherapy bai haifar da sassauci a cikin bargon ƙashi ba. A ranar 27 ga Yuli, Yesheng ya sami jiko na ƙwayoyin CD7 CAR-T, sannan aka haɗa shi da maganin chemotherapy tare da maganin ƙwayoyin CAR-T na autologous CD7. Kwanaki goma sha biyar bayan jiko, gwajin bargon ƙashi ya nuna rashin lafiya mai tsanani, tare da amsawar cytokine release syndrome (CRS) na aji 1 kuma babu wani mummunan sakamako na tsarin jijiyoyi na tsakiya.